Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.
about
Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrenceZebrafish small molecule screens: Taking the phenotypic plungeOptical metabolic imaging of treatment response in human head and neck squamous cell carcinomaPhotothermal optical lock-in optical coherence tomography for in vivo imagingMagnetization Transfer MRI Contrast May Correlate with Tissue Redox State in Prostate CancerMetabolic fingerprinting of bacteria by fluorescence lifetime imaging microscopy.Multicolor two-photon imaging of endogenous fluorophores in living tissues by wavelength mixing.The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts.Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer.Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.In vivo nonlinear spectral imaging as a tool to monitor early spectroscopic and metabolic changes in a murine cutaneous squamous cell carcinoma model.High-throughput measurements of the optical redox ratio using a commercial microplate reader.Collagen density and alignment in responsive and resistant trastuzumab-treated breast cancer xenograftsTumor mechanics and metabolic dysfunction.Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.Deconvolution of fluorescence lifetime imaging microscopy by a library of exponentials.Correlating two-photon excited fluorescence imaging of breast cancer cellular redox state with seahorse flux analysis of normalized cellular oxygen consumption.Temporal binning of time-correlated single photon counting data improves exponential decay fits and imaging speed.Metabolic Imaging of Head and Neck Cancer OrganoidsA quantitative framework for the analysis of multimodal optical microscopy imagesDrug response in organoids generated from frozen primary tumor tissues.Label-free imaging of metabolism and oxidative stress in human induced pluripotent stem cell-derived cardiomyocytesOptical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response.In Vivo Visualization of Stromal Macrophages via label-free FLIM-based metabolite imaging.Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancerDepth-resolved analytical model and correction algorithm for photothermal optical coherence tomographyImaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow SpheroidsTwo-photon excited fluorescence of intrinsic fluorophores enables label-free assessment of adipose tissue functionmTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancerSpatial dynamics of SIRT1 and the subnuclear distribution of NADH species.Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism.In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment.Blind deconvolution estimation of fluorescence measurements through quadratic programming.Quadratic blind linear unmixing: A graphical user interface for tissue characterization.Autofluorescence imaging captures heterogeneous drug response differences between 2D and 3D breast cancer cultures.Transient absorption imaging of hemes with 2-color, independently tunable visible-wavelength ultrafast source.Optical metabolic imaging quantifies heterogeneous cell populations.Autofluorescence flow sorting of breast cancer cell metabolism.
P2860
Q27010314-91A524E2-F1B3-40F8-A352-610C740C8A74Q28073655-96280A72-576A-4BD4-A520-589CDD2F264DQ28540413-3218ED8B-5D70-45DE-9472-35D99961045EQ30408505-E3EDEE48-3C5A-49C8-9FF8-1EE417E79838Q33621051-E062AF29-4A5D-48AF-A45D-C4DD52302065Q33807803-5FC332E2-9FEF-4A91-8107-5941A3094EECQ33812892-9938A82A-A5F3-41F9-B652-F6DEC8FC7F43Q33823191-D428B5C4-103E-4E94-8583-92F1B34A2675Q33915825-7180C6EA-97FC-4E0B-95B7-BBF0F95E9921Q34205196-A7B0EE52-63FD-4806-BA56-1844F099CE32Q34611146-E78FB322-AC20-4067-BAAE-7A939C24D229Q34848837-6549B95D-6B9B-4C2F-9613-BF52141BFCA4Q35029198-F1A93DE2-2673-4780-B3D1-2DD5E2748E2CQ35105141-7CFD847D-04B6-46A3-9BFC-5575B43F567BQ35117423-B073AE77-457D-4254-84ED-2CA5A5649694Q35740663-66CF9B56-63C8-4E5E-AA8F-CF833C5AD985Q35774073-5177AA38-05F8-4104-BC34-77D99B7817A4Q36051797-33E09D41-B5F2-45EA-B812-56CA2F42FEB8Q36083518-A17B736E-EA48-466A-B6E4-952DDD6B9766Q36252747-B20D1D0B-88B6-4AD5-83D2-538C97E8105AQ36301593-44AAF6F2-12A6-4783-A8F0-F0734EBFCDA4Q36438337-8FC07290-A088-4D9B-AB77-FC1C7F727A0EQ36912011-8F22AF7B-7B8D-4669-89C7-8A67209DEC07Q36922301-67338FB2-0D46-4B64-B007-EA539B501B54Q36934018-AA1A2C7B-0C4C-4B52-86AD-2BD5088CFF9DQ36941952-BEE6D8A5-8ABB-4975-8C6E-720E7FB65C4FQ37096669-E99F137B-12A0-47DF-A7AE-779C89DE12A2Q37103173-F72FA5BE-2F13-41CA-BC2F-57F369C50F8CQ37130950-DBD3B1A6-DE8F-4A97-A01A-8C4C151F3B1EQ37153734-0DA2FE0D-DE27-4F57-B148-946EFB6EE284Q37295289-86CB5904-8243-460C-BB15-F91DB6C9A997Q37417990-DB60C626-F179-40D6-AB74-3D40E00EA00CQ37429091-FC5B89D7-AF5D-460F-9D07-C4A4347C324AQ38809622-54649B2F-DBB7-48F7-901B-296D17D3B7D3Q38848135-F23FBF31-D398-429D-9F6A-69902D40A933Q39793364-07CC7AD8-7F7D-465A-87CB-FCFD570317A5Q41068676-42C318D9-A76F-47C5-BBEA-A1A9E4AAFC7DQ41069821-FCB60EE9-F947-41FD-9994-92086F8256AFQ41205147-D7F30C2F-B6C4-4F85-AA5D-14ADCF83A140Q41285978-6024CA2B-22B9-48C8-806B-1889195D4F89
P2860
Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optical metabolic imaging iden ...... ent response in breast cancer.
@en
Optical metabolic imaging iden ...... ent response in breast cancer.
@nl
type
label
Optical metabolic imaging iden ...... ent response in breast cancer.
@en
Optical metabolic imaging iden ...... ent response in breast cancer.
@nl
prefLabel
Optical metabolic imaging iden ...... ent response in breast cancer.
@en
Optical metabolic imaging iden ...... ent response in breast cancer.
@nl
P2093
P2860
P1433
P1476
Optical metabolic imaging iden ...... ent response in breast cancer.
@en
P2093
Alec Lafontant
Alex J Walsh
Carlos L Arteaga
Donna J Hicks
H Charles Manning
Melissa C Skala
Rebecca S Cook
P2860
P304
P356
10.1158/0008-5472.CAN-13-0527
P407
P577
2013-10-01T00:00:00Z